Based on molecular and histologic evidence, BC can be divided into 3 categories: BC expressing human epidermal receptor 2, BC expressing hormone receptor (estrogen receptor [ER] or progesterone receptor), and triple-negative BC (TNBC) [109]. Here, PGR is linked to breast cancer.